Evidence map›Paper›PMID 42210087›Full record

ArticleBMC infectious diseases2026

First-week absolute lymphocyte count dynamics and 28-day mortality in older adults with sepsis.

Esra Yakışık Aktekin, Behiye Deniz Kosovalı, Şerife Gökbulut Bektaş, Deniz Erdem, Firdevs Tuğba Bozkurt Biçer

Abstract read
In one paragraph

Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Esra Yakışık AktekinDepartment of Intensive Care Medicine, Bilkent City Hospital, Üniversiteler, 1604. Cd. No:9, Çankaya, Ankara, 06800, Turkey.
Behiye Deniz KosovalıDepartment of Intensive Care Medicine, Bilkent City Hospital, Üniversiteler, 1604. Cd. No:9, Çankaya, Ankara, 06800, Turkey.
Şerife Gökbulut BektaşDepartment of Intensive Care Medicine, Bilkent City Hospital, Üniversiteler, 1604. Cd. No:9, Çankaya, Ankara, 06800, Turkey.
Deniz ErdemDepartment of Intensive Care Medicine, Bilkent City Hospital, Üniversiteler, 1604. Cd. No:9, Çankaya, Ankara, 06800, Turkey.
Firdevs Tuğba Bozkurt BiçerDepartment of Intensive Care Medicine, Bilkent City Hospital, Üniversiteler, 1604. Cd. No:9, Çankaya, Ankara, 06800, Turkey. drtugbaicu@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSepsis is a syndrome in which immune recovery is impaired and the clinical course becomes more severe, particularly in older patients. Although lymphopenia is an easily monitored indicator of sepsis-associated immune dysfunction, the clinical significance of daily lymphocyte changes during the first week in older intensive care patients remains unclear. This study evaluated associations between absolute lymphocyte count (ALC) dynamics, 28-day mortality, and a culture-based secondary microbiological outcome in patients aged ≥ 65 years with sepsis.

methodsIn this single-center retrospective cohort, patients aged ≥ 65 years admitted from the emergency department to the ICU with sepsis between January 1, 2022 and December 31, 2025 were included. Daily ALC during days 1-7 was categorized as no lymphopenia (≥ 1000 cells/mm³), moderate lymphopenia (500-999 cells/mm³), or severe lymphopenia (< 500 cells/mm³). The primary outcome was 28-day all-cause mortality; the secondary outcome was 28-day nosocomial culture positivity.

resultsAmong 566 patients, the mean age was 80.7 ± 8.0 years, 48.2% were female, and 28-day mortality was 41.0%. ALC was available for all patients through ICU day 3 and for 514/566 patients (90.8%) on ICU day 7; later non-availability reflected shortened observation time rather than random laboratory omission. Severe lymphopenia declined from 33.9% on day 1 to 24.7% on day 7. Mortality was highest in severe lymphopenia, with FDR-corrected significance on day 2 and days 4-7. In the prespecified day-4 multivariable model, severe lymphopenia was independently associated with mortality (aOR 1.84, 95% CI 1.08-3.14; p = 0.025), whereas moderate lymphopenia was not. Increasing severe-lymphopenia burden was also associated with mortality during days 1-4 (aOR 1.16; p = 0.033) and days 1-7 (aOR 1.13; p = 0.013). Nosocomial culture positivity showed unadjusted late-week associations, but not after adjustment.

conclusionIn older ICU patients with sepsis, day-4 severe lymphopenia and first-week severe-lymphopenia burden were associated with 28-day mortality. The culture-based secondary outcome was not confirmed after adjustment and should be considered exploratory. First-week ALC monitoring may aid bedside risk stratification, but prospective multicenter validation is needed.

Indexed as

SepsisAgedAged, 80 and overFemaleHumansIntensive Care UnitsLymphocyte CountLymphopeniaMaleRetrospective StudiesElderly patientIntensive careLymphopeniaMortalityNosocomial culture positivitySepsis

Identifiers

PMID42210087
PMCPMC13412316

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.